SEC Comment Letter for VOLITIONRX LTD (VNRX) (CIK 0000093314) (VNRX) — Oct 12, 2018
VOLITIONRX LTD (VNRX) (CIK 0000093314)
Date: Oct. 12, 2018 · CIK: 0000093314 · Accession: 0000000000-18-032118
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227731
Letter
October 12, 2018 Cameron Reynolds President and Chief Executive Officer VolitionRx Limited 1 Scotts Road #24-05 Shaw Centre Singapore 228208 Re:VolitionRx Limited Registration Statement on Form S-3 Filed October 5, 2018 File No. 333-227731 Dear Mr. Reynolds: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dorrie Yale at 202-551-8776 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Marc G. Alcser, Esq.
Show Raw Text
October 12, 2018
Cameron Reynolds
President and Chief Executive Officer
VolitionRx Limited
1 Scotts Road
#24-05 Shaw Centre
Singapore 228208
Re:VolitionRx Limited
Registration Statement on Form S-3
Filed October 5, 2018
File No. 333-227731
Dear Mr. Reynolds:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dorrie Yale at 202-551-8776 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Marc G. Alcser, Esq.